<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35591849</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2405-6308</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and translational radiation oncology</Title>
          <ISOAbbreviation>Clin Transl Radiat Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience.</ArticleTitle>
        <Pagination>
          <StartPage>37</StartPage>
          <EndPage>43</EndPage>
          <MedlinePgn>37-43</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ctro.2022.04.012</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">We report on our experience of using Helical Tomotherapy (HT) in the context of post-mastectomy radiation therapy (PMRT) with or without immediate implant-based breast Reconstruction (IBR).</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">The study included a total of 173 patients who underwent PMRT with HT between 2013 and 2015 in our institution (87 immediate breast reconstructions with retropectoral implants (IBR + ), 86 without reconstructions (IBR-)). The chest wall target volume included subcutaneous tissue and pectoralis muscle and excluded the posterior region of the implant as well as the ribs.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Median time to initiation of the first adjuvant treatment from mastectomy was similar between the two groups (p = 0.134). Dose coverage to the chest wall was significantly improved for the IBR + group (V95% = 95.1 % versus 92.0 %; p &lt; 0.0001). The irradiated volume of the ipsilateral lung was significantly decreased in the IBR + group with a median V20Gy of 11.6 %, compared to 15.2 % for the control group (p &lt; 0.0001). The median heart V15Gy was also significantly lower in the IBR + group than in the control group (1.7 vs 2.5 %; p = 0.0280). The reconstruction failure rate was 14.9% (n = 13). After a median follow-up of 65 months, loco regional recurrence rate was low in both groups: 3 patients (3.4%) in the IBR + group and 5 patients (5.8%) in the control group, without any local recurrence in the posterior part of the implant.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The presence of a breast implant reduces cardiac and pulmonary doses during Tomotherapy irradiation, without compromising oncological outcomes.</AbstractText>
          <CopyrightInformation>© 2022 The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dejean</LastName>
            <ForeName>Romain</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chaltiel</LastName>
            <ForeName>Leonor</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Biostastistics Units, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Izar</LastName>
            <ForeName>Françoise</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chira</LastName>
            <ForeName>Ciprian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leray</LastName>
            <ForeName>Helene</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jouve</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simon</LastName>
            <ForeName>Luc</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Engineering and Medical Physics, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Massabeau</LastName>
            <ForeName>Carole</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Transl Radiat Oncol</MedlineTA>
        <NlmUniqueID>101713416</NlmUniqueID>
        <ISSNLinking>2405-6308</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Breast implant</Keyword>
        <Keyword MajorTopicYN="N">HT, Helical Tomotherapy</Keyword>
        <Keyword MajorTopicYN="N">Helical tomotherapy</Keyword>
        <Keyword MajorTopicYN="N">IBR, Immediate Breast Reconstruction</Keyword>
        <Keyword MajorTopicYN="N">Immediate Breast reconstruction</Keyword>
        <Keyword MajorTopicYN="N">PMRT, Post-mastectomy Radiation therapy</Keyword>
        <Keyword MajorTopicYN="N">Post-mastectomy radiation therapy</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>2</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35591849</ArticleId>
        <ArticleId IdType="pmc">PMC9112056</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ctro.2022.04.012</ArticleId>
        <ArticleId IdType="pii">S2405-6308(22)00035-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>McGale P., Taylor C., Correa C., et al.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–2135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5015598</ArticleId>
            <ArticleId IdType="pubmed">24656685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Recht A., Comen E.A., Fine R.E., Fleming G.F., Hardenbergh P.H., Ho A.Y., et al.  Postmastectomy radiotherapy: An American Society of clinical oncology, American society for radiation oncology, and society of surgical oncology focused guideline update. J Clin Oncol. 2016;34(36):4431–4442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27646947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albornoz C.R., Bach P.B., Mehrara B.J., Disa J.J., Pusic A.L., McCarthy C.M., et al.  A paradigm shift in U.S. Breast reconstruction: Increasing implant rates. Plast Reconstr Surg. 2013;131(1):15–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23271515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dauplat J., Kwiatkowski F., Rouanet P., Delay E., Clough K., Verhaeghe J.L., et al.  Quality of life after mastectomy with or without immediate breast reconstruction. Br J Surg. 2017;104(9):1197–1206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28401542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agarwal S., Kidwell K.M., Farberg A., Kozlow J.H., Chung K.C., Momoh A.O. Immediate Reconstruction of the Radiated Breast: Recent Trends Contrary to Traditional Standards. Ann Surg Oncol. 2015;22(8):2551–2559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4821406</ArticleId>
            <ArticleId IdType="pubmed">25564172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Motwani S.B., Strom E.A., Schechter N.R., Butler C.E., Lee G.K., Langstein H.N., et al.  The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66(1):76–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16765534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohri N., Cordeiro P.G., Keam J., Ballangrud A., Shi W., Zhang Z., et al.  Quantifying the impact of immediate reconstruction in postmastectomy radiation: A large, dose-volume histogram-based analysis. Int J Radiat Oncol Biol Phys. 2012;84(2):e153–e159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22560544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koutcher L., Ballangrud Å., Cordeiro P.G., McCormick B., Hunt M., Zee K.J.V., et al.  Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction. Radiother Oncol. 2010;94(3):319–323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20096946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goddu S.M., Chaudhari S., Mamalui-Hunter M., Pechenaya O.L., Pratt D., Mutic S., et al.  Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast Technique. Int J Radiat Oncol Biol Phys. 2009;73(4):1243–1251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19251096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reynders T., Tournel K., De Coninck P., Heymann S., Vinh-Hung V., Van Parijs H., et al.  Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments. Radiother Oncol. 2009;93(1):71–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19682758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashenafi M., Boyd R.A., Lee T.K., Lo K.K., Gibbons J.P., Rosen I.I., et al.  Feasibility of Postmastectomy Treatment With Helical TomoTherapy. Int J Radiat Oncol Biol Phys. 2010;77(3):836–842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19879697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massabeau C., Fournier-Bidoz N., Wakil G., Castro Pena P., Viard R., Zefkili S., et al.  Implant breast reconstruction followed by radiotherapy: Can helical tomotherapy become a standard irradiation treatment? Med Dosim. 2012;37(4):425–431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22534136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Offersen B.V., Boersma L.J., Kirkove C., Hol S., Aznar M.C., Biete Sola A., et al.  ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114(1):3–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25630428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mutter R.W. ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer. Radiother Oncol. 2019;141:329–330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7740619</ArticleId>
            <ArticleId IdType="pubmed">31451284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jethwa K.R., Kahila M.M., Whitaker T.J., Harmsen W.S., Corbin K.S., Park S.S., et al.  Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT) Breast Cancer Res Treat. 2017;164(1):237–244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28417333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darby S.C., Ewertz M., Hall P. Ischemic heart disease after breast cancer radiotherapy. N Engl J Med. 2013;368(26):2527. doi: 10.1056/NEJMc1304601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc1304601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lind P.A., Wennberg B., Gagliardi G., Rosfors S., Blom-Goldman U., Lideståhl A., et al.  ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys. 2006;64(3):765–770.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16257129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xavier Harmeling J., Kouwenberg C.A.E., Bijlard E., Burger K.N.J., Jager A., Mureau M.A.M. The effect of immediate breast reconstruction on the timing of adjuvant chemotherapy: a systematic review. Breast Cancer Res Treat. 2015;153(2):241–251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559567</ArticleId>
            <ArticleId IdType="pubmed">26285643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gieni M., Avram R., Dickson L., Farrokhyar F., Lovrics P., Faidi S., et al.  Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: A meta-analysis. Breast. 2012;21(3):230–236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22225710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P., Li C.-Z., Wu C.-T., Jiao G.-M., Yan F., Zhu H.-C., et al.  Comparison of immediate breast reconstruction after mastectomy and mastectomy alone for breast cancer: A meta-analysis. Eur J Surg Oncol. 2017;43(2):285–293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27503441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X., Zhu C., Gu Y., Coleman W.B. The prognosis of breast cancer patients after mastectomy and immediate breast reconstruction: A meta-analysis. PLoS ONE. 2015;10(5):e0125655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449019</ArticleId>
            <ArticleId IdType="pubmed">26024490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ricci J.A., Epstein S., Momoh A.O., Lin S.J., Singhal D., Lee B.T. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. J Surg Res. 2017;218:108–116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28985836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shumway D.A., Momoh A.O., Sabel M.S., Jagsi R. Integration of breast reconstruction and postmastectomy radiotherapy. J Clin Oncol. 2020;38(20):2329–2340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32442071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Momoh A.O., Ahmed R., Kelley B.P., Aliu O., Kidwell K.M., Kozlow J.H., et al.  A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Ann Surg Oncol. 2014;21(1):118–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4153348</ArticleId>
            <ArticleId IdType="pubmed">24081801</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
